Remove 2016 Remove Clinical Trials Remove Cultivation Remove History
article thumbnail

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.

DEA 104
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. Some hemp cultivation is permitted in Japan, but on a relatively very small scale. But in modern times? The future of weed legalization in Japan.

Law 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

North America Legal Cannabis Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com

Cannabis Law Report

Rising cannabis cultivation, the emergence of local players, favorable government initiatives, and increasing adoption of cannabis-based products are some of the key factors supporting the market growth in the country. Illicit cannabis trade due to surplus cultivation. History of Medical Use of Cannabis in North America.

article thumbnail

Apparently Aussie Cannabis Stock Is “Smoke Without Fire.” All Australians Know At The Moment Smoke & Fire Come Together

Cannabis Law Report

Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. Cann Group (ASX: CAN ) was the first Australian company to receive a licence and permit from the government to cultivate medical cannabis in Australia. Give me my free report!

article thumbnail

Outline – Hopgood & Ganim Lawyers: Medicinal Cannabis in Australia: issues and regulations

Cannabis Law Report

Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. the person’s history of compliance with the NDA. Josh Hunt – Partner.

article thumbnail

UK Parliament Finds A Few Moments To Discuss Medical Cannabis & Emma Appleby Affair In Between Brexit Chaos

Cannabis Law Report

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

article thumbnail

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.